Predictors of Overall Survival Among Patients Treated With Sirolimus/Tacrolimus vs Methotrexate/Tacrolimus for GvHD Prevention
Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2017.63
Full Text
Open PDFAbstract
Available in full text
Date
April 3, 2017
Authors
Publisher
Springer Science and Business Media LLC